CMMB
Chemomab Therapeutics Ltd.
NASDAQ · Healthcare · Biotechnology · IL
$2.71
−4.24%Aug 19, 2026, 12:26 UTC
Chemomab Therapeutics announced that its planned merger with Scipher Medicine is advancing, with closing expected by year-end.
Source:Aug 19, 2026, 12:26 UTC
Chemomab Therapeutics announced its second quarter 2026 financial results and provided a corporate update.
Source:Jul 8, 2026, 11:35 UTC
Chemomab Therapeutics and Scipher Medicine announced a merger agreement to advance nebokitug in an AI-powered Phase 2 trial for rheumatoid arthritis.